Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.22M Sell
44,368
-2,852
-6% -$63K 0.01% 1023
2026
Q1
$690K Sell
47,220
-383
-0.8% -$5.62K 0.01% 1212
2025
Q4
$602K Buy
47,603
+249
+0.5% +$3.67K ﹤0.01% 1255
2025
Q3
$728K Buy
47,354
+6,206
+15% +$100K 0.01% 1177
2025
Q2
$647K Buy
41,148
+330
+0.8% +$5K 0.01% 1195
2025
Q1
$780K Sell
40,818
-1,019
-2% -$22.3K 0.01% 1110
2024
Q4
$997K Buy
41,837
+1,356
+3% +$37.9K 0.01% 1053
2024
Q3
$1.13M Buy
40,481
+4,609
+13% +$130K 0.01% 1001
2024
Q2
$938K Sell
35,872
-1,131
-3% -$23.5K 0.01% 1059
2024
Q1
$809K Sell
37,003
-11,846
-24% -$254K 0.01% 1131
2023
Q4
$1.14M Sell
48,849
-1,949
-4% -$39.2K 0.01% 1115
2023
Q3
$1M Sell
50,798
-1,500
-3% -$29.5K 0.01% 1108
2023
Q2
$1.19M Sell
52,298
-2,996
-5% -$60.3K 0.01% 1066
2023
Q1
$1.09M Sell
55,294
-41,475
-43% -$796K 0.01% 1089
2022
Q4
$1.66M Buy
+96,769
New +$1.72M 0.01% 959

Other funds holding RXO

Amalgamated Bank's RXO Position: Q2 2026 in Review

Amalgamated Bank reduced its RXO (RXO) stake by 6% in Q2 2026, selling an estimated $63K and leaving 44,368 shares worth $1.22M. The position accounts for 0.01% of the portfolio, ranked #1023.

Amalgamated Bank first reported a position in RXO in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.66M in Q4 2022. 135 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Amalgamated Bank held 44,368 shares of RXO worth $1.22M as of Q2 2026.
  • Amalgamated Bank sold 2,852 RXO shares in Q2 2026, an estimated $63K.
  • RXO made up 0.01% of Amalgamated Bank's portfolio in Q2 2026, its #1023 holding.
  • Amalgamated Bank first reported a position in RXO in Q4 2022 and has held it in 15 quarters since.
  • Amalgamated Bank's RXO position peaked at $1.66M in Q4 2022.
  • 135 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.